# Training for Clinical Trials with the IMPACT-AD Program

Page: https://stenobird.com/podcast/dementia-matters-60044/training-for-clinical-trials-with-the-impact-ad-program
Text version: https://stenobird.com/podcast/dementia-matters-60044/training-for-clinical-trials-with-the-impact-ad-program.md
Podcast: [Dementia Matters](https://stenobird.com/podcast/dementia-matters-60044)
Published: 2026-03-10T11:00:00+00:00
Episode link: https://dementiamatters.podbean.com/e/training-for-clinical-trials-with-the-impact-ad-program/
Audio file: https://mcdn.podbean.com/mf/web/9hem29zirtpq9d2p/Grill_Raman_Carillo_Final.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/dementia-matters-60044/episodes/training-for-clinical-trials-with-the-impact-ad-program
Duration seconds: 2193

## Resource

Are you a researcher interested in getting involved in Alzheimer’s disease and related dementias (ADRD) clinical trials? The Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD, or IMPACT-AD, program brings investigators from around the world together for a week of professional development and education. IMPACT-AD co-directors Dr. Josh Grill and Dr. Rema Raman, as well as faculty member Dr. Maria Carrillo, join the podcast to explain what the program entails, their mission and more. Guests: Josh Grill, PhD, director, Institute for Memory Impairments and Neurological Disorders, professor, University of California, Irvine (UCI), co-director, IMPACT-AD, Rema Raman, PhD, co-director, IMPACT-AD, director, Biostatistics Section and Recruitment, Engagement, and Retention Section, Alzheimer’s Therapeutic Research Institute (ATRI), professor of neurology, University of Southern California (USC), and Maria Carrillo, PhD, chief science officer, medical affairs lead, Alzheimer’s Association, co-principal investigator, Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET), co-principal investigator, Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS) Show Notes Learn more and apply for the 2026 IMPACT-AD program on their website. Listen to our previous episode with Rema Raman, “Making an IMPACT: Advancing Alzheimer’s Disease Clinical Trials Through Workforce Development and Inclusivity,” on our website, Spotify, Apple Podcasts and wherever you listen. Listen to our previous episodes with Josh Grill, “The Case for Disclosing Biomarker Results to Alzheimer’s Research Participants” and “Improving Registries and Representation in Alzheimer’s Disease Research” on our website. Read more about Dr. Raman in her USC Keck School of Medicine Profile. Rea…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/dementia-matters-60044/episodes/training-for-clinical-trials-with-the-impact-ad-program/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/dementia-matters-60044/training-for-clinical-trials-with-the-impact-ad-program.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.